Here is a complete list of Lab publications on PubMed
A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low grarde gliomas.
Apfelbaum April, Morin E, et al. Nature Commun. 2025 July 31;16(1):7018. doi: 1038/s41467-025-61820-z.
Deep learning volumetrics reveals distinct clinical trajectories for pediatric low-grade gliomas under surveillance: A multicenter study.
Climent Pardo JC, et al. Neuroncol Advances. 2025 July 1;7(1):vdaf145. doi:10.1093/noajnl/vdaf145. eCollection 2025 Jan-Dec. (Collaborating lab)
Longitudinal risk prediction for pediatric glioma with temporal deep learning
Tak, et al. NEJM AI. 2025 May;2(5):10.1056/aioa2400703 doi:10.1056/aioa2400703. Epub 2025 April 24. (Collaborating lab)
Incidental Diffuse Midline Glioma, H3 K27-altered of the pons without significant coalterations
Yeo, et al. JCO Precis Oncol. 2025 June: 9:e2400944 doi:10.1200/PO-24-00944. Epub 2025 Jun 6
Recurrent breakpoints in the BRD4 locus reduce toxicity associated with gene amplification
Wala, et al. Cell Genom. 2025 April 9; 5(4):100815. doi:10.1016/j.xgen.2025.100815. Epub 2025 March 19.
Effective targeting of PDGFRA-altered-high-grade glioma with avapritinib
Mayr L, et al. Cancer Cell. 2025 April 14;43(4):740-756. doi:10.1016/j.ccell.2025.02.018. Epub 2025 March 13. (Collaborating lab)
A compendium of amplification-related gain of sensitivity genes in human cancer.
Rendo V, et al. Nature Commun. 2025 Jan 27;16(1):1077. doi:10.1038/s41467-025-56301-2. (Collaborating lab)